Dixon Hubard Feinour & Brown’s Zimmer Biomet ZBH Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,576	Closed	-$202K	–	313
2022 Q1	$202K	Sell	1,576 -99	-6%	-$11.9K	0.02%	296
2021 Q4	$207K	Buy	+1,675	New	+$219K	0.02%	287
2021 Q2	–	Sell	-3,921	Closed	-$565K	–	221
2021 Q1	$565K	Buy	3,921 +2,011	+105%	+$312K	0.07%	145
2020 Q4	$252K	Hold	1,910	–	–	0.06%	151
2020 Q3	$252K	Hold	1,910	–	–	0.06%	151
2020 Q2	$249K	Sell	1,910 -199	-9%	-$22.9K	0.06%	158
2020 Q1	$207K	Hold	2,109	–	–	0.07%	152
2019 Q4	$307K	Hold	2,109	–	–	0.08%	140
2019 Q3	$281K	Sell	2,109 -13	-0.6%	-$1.68K	0.08%	141
2019 Q2	$243K	Buy	2,122 +13	+0.6%	+$1.52K	0.07%	153
2019 Q1	$262K	Hold	2,109	–	–	0.08%	145
2018 Q4	$212K	Hold	2,109	–	–	0.08%	144
2018 Q3	$269K	Hold	2,109	–	–	0.07%	144
2018 Q2	$228K	Hold	2,109	–	–	0.07%	149
2018 Q1	$223K	Hold	2,109	–	–	0.06%	170
2017 Q4	$247K	Hold	2,109	–	–	0.07%	163
2017 Q3	$240K	Hold	2,109	–	–	0.07%	158
2017 Q2	$263K	Hold	2,109	–	–	0.08%	152
2017 Q1	$250K	Hold	2,109	–	–	0.07%	151
2016 Q4	$211K	Sell	2,109 -101	-5%	-$10.8K	0.07%	156
2016 Q3	$279K	Hold	2,210	–	–	0.09%	142
2016 Q2	$258K	Hold	2,210	–	–	0.08%	146
2016 Q1	$248K	Hold	2,210	–	–	0.08%	145
2015 Q4	$220K	Hold	2,210	–	–	0.07%	156
2015 Q3	$202K	Hold	2,210	–	–	0.07%	152
2015 Q2	$234K	Hold	2,210	–	–	0.07%	156
2015 Q1	$252K	Hold	2,210	–	–	0.07%	171
2014 Q4	$243K	Hold	2,210	–	–	0.08%	170
2014 Q3	$216K	Hold	2,210	–	–	0.07%	173
2014 Q2	$223K	Sell	2,210 -232	-10%	-$22.6K	0.07%	177
2014 Q1	$224K	Buy	+2,442	New	+$225K	0.08%	173

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dixon Hubard Feinour & Brown's ZBH Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 1,576 shares — an estimated $202K sold.

Dixon Hubard Feinour & Brown first reported a position in ZBH in Q1 2014 and held it in 31 quarters. The position peaked at $565K in Q1 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Dixon Hubard Feinour & Brown reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Dixon Hubard Feinour & Brown sold 1,576 Zimmer Biomet shares in Q2 2022, an estimated $202K.
Dixon Hubard Feinour & Brown first reported a position in Zimmer Biomet in Q1 2014 and held it in 31 quarters.
Dixon Hubard Feinour & Brown's Zimmer Biomet position peaked at $565K in Q1 2021.
956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.